Evozyne
Martin Brennan is a Research Scientist II specializing in Microfluidics at Evozyne since September 2021. Previously, Martin held the position of Postdoctoral Researcher at the University of Illinois Chicago, contributing to advanced research in the field.
Evozyne
1 followers
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.